TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 89 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2014. The put-call ratio across all filers is 8.57 and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $242,426 | -11.8% | 8,348 | -9.1% | 0.00% | 0.0% |
| Q3 2022 | $275,000 | -26.5% | 9,183 | -11.4% | 0.00% | 0.0% |
| Q2 2022 | $374,000 | -33.8% | 10,361 | +12.3% | 0.00% | -83.3% |
| Q1 2020 | $565,000 | -81.0% | 9,224 | -76.6% | 0.01% | -73.9% |
| Q3 2019 | $2,975,000 | +334.3% | 39,432 | +392.0% | 0.02% | +283.3% |
| Q2 2019 | $685,000 | -50.3% | 8,014 | -42.8% | 0.01% | 0.0% |
| Q3 2018 | $1,378,000 | +66.2% | 14,014 | +142.2% | 0.01% | -25.0% |
| Q1 2016 | $829,000 | -83.1% | 5,787 | -81.8% | 0.01% | -82.6% |
| Q4 2015 | $4,911,000 | +16.7% | 31,779 | +7.9% | 0.05% | -11.5% |
| Q3 2015 | $4,209,000 | -36.8% | 29,457 | -36.5% | 0.05% | -40.2% |
| Q2 2015 | $6,665,000 | +27.6% | 46,383 | +25.3% | 0.09% | +27.9% |
| Q1 2015 | $5,222,000 | -63.7% | 37,029 | -61.8% | 0.07% | -64.2% |
| Q4 2014 | $14,377,000 | +182.1% | 97,017 | +192.9% | 0.19% | +156.8% |
| Q3 2014 | $5,097,000 | +226.9% | 33,128 | +198.0% | 0.07% | +221.7% |
| Q2 2014 | $1,559,000 | – | 11,116 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Claret Asset Management Corp | 86,474 | $6,524,000 | 1.34% |
| Analyst IMS Investment Management Services Ltd. | 28,438 | $2,143,000 | 0.64% |
| ALGERT GLOBAL LLC | 20,876 | $1,575,000 | 0.59% |
| Quantinno Capital Management LP | 9,351 | $706,000 | 0.48% |
| Crestline Management, LP | 37,000 | $2,792,000 | 0.45% |
| Empirical Finance, LLC | 9,561 | $721,000 | 0.20% |
| BRANDES INVESTMENT PARTNERS, LP | 55,065 | $5,469,000 | 0.14% |
| FORT, L.P. | 9,672 | $730,000 | 0.14% |
| CAXTON ASSOCIATES LP | 8,865 | $669,000 | 0.13% |
| ACADIAN ASSET MANAGEMENT LLC | 330,448 | $24,928,000 | 0.11% |